X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

OncoImmunology

期刊標題檢索 ONCOIMMUNOLOGY 最新評論: Review speed: 3.0 | Submission success rate: 50.0 Experience sharing... (2024-07-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[OncoImmunology]您好,您是該頁面的第 55382 位訪客。

期刊簡介
期刊名稱OncoImmunology OncoImmunology
LetPub Score
7.5
50 ratings
Rate

Reputation
8.8

Influence
6.6

Speed
7.0

期刊簡稱ONCOIMMUNOLOGY
ISSN2162-402X
h-index49
CiteScore
CiteScoreSJRSNIPCiteScore Rank
12.802.3450.987
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q140 / 404
Category: Medicine
Subcategory: Immunology and Allergy
Q130 / 233
Category: Medicine
Subcategory: Immunology
Q134 / 236

自引率 (2023-2024)3.10%自引率趨勢
掲載範囲
Tumor immunology deals with the natural or therapy-induced recognition of cancers, as well as with the intricate interplay between oncogenesis, inflammation and immunosurveillance. We now create a new, high-profile journal, OncoImmunology, that specifically deals with tumor immunology. Recent progress has allowed for the first clinical demonstration (and FDA approval) of anticancer immunotherapies. There is also an ever growing suspicion that - unexpectedly - many of the currently used chemotherapeutic agents depend in their efficacy on the active contribution of immune effectors. To use a drastic metaphor, oncologists who applied successful chemotherapeutic (or radiotherapeutic) regimens have taken advantage of the immune system's capacity to recognize tumor-specific or tumor-associated antigens and to control cancer (stem) cell growth, without being aware of the invisible helping hands. As a result, immunological biomarkers are becoming ever more important to determine the prognosis of cancers and to predict the efficacy of chemotherapies. There is also a strong rationale in favor of combining conventional anticancer therapies with immunotherapies.
OncoImmunology will accept high-profile submissions in the fundamental, translational and clinical areas of tumor immunology. Submissions dealing with solid or hematological cancers, inflammation, innate and acquired immune responses will be welcome.
官方網站http://www.tandfonline.com/loi/koni20
在線稿件提交https://www.editorialmanager.com/ONCOIMM
開放訪問No
出版商Landes Bioscience
主題領域ONCOLOGYIMMUNOLOGY
出版國/地區UNITED STATES
發行頻率
創刊年0
每年文章數114每年文章數趨勢
黃金OA百分比100.00%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ130/181
ONCOLOGYSCIEQ144/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2162-402X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 24 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【OncoImmunology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Science ImmunologyH-index: 0

    CiteScore: 32.90
    Journal of Allergy and Clinical Immunology-In PracticeH-index: 40

    CiteScore: 11.10
    Cancer Immunology ResearchH-index: 62

    CiteScore: 15.60
    npj VaccinesH-index: 8

    CiteScore: 11.90
    OncoImmunologyH-index: 58

    CiteScore: 12.80
    ALLERGOLOGY INTERNATIONALH-index: 45

    CiteScore: 12.60
    HLAH-index: 93

    CiteScore: 3.00
    Immunity & AgeingH-index: 38

    CiteScore: 10.20
    Clinical and Translational AllergyH-index: 28

    CiteScore: 7.50
    Immune NetworkH-index: 11

    CiteScore: 10.30
    學科內最受檢索的期刊 頁面查看次數
    Journal of Inflammation Research74079
    Cancer Immunology Research57215
    OncoImmunology50279
    Science Immunology39953
    npj Vaccines29301
    Human Vaccines & Immunotherapeutics24537
    Human Vaccines & Immunotherapeutics24518
    Endocrine Metabolic & Immune Disorders-Drug Targets20829
    Journal of Allergy and Clinical Immunology-In Practice18770
    Allergy Asthma & Immunology Research18538
  •  

    OncoImmunology OncoImmunology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)
  [OncoImmunology] 的評論撰寫評論
作者: Toby Nahum


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-25 16:49:03 評論於
Review speed: 3.0 | Submission success rate: 50.0
Experience sharing: The big boss said this is a journal for connections, not recommended for ordinary people to submit.
(0) 讚! | Toby Nahum

作者: 光明谷玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-29 16:52:01 評論於
Can references be included in the word count? And can I delete down to 5,000 words?
(0) 讚! | 光明谷玉

作者: 八极望亭


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-06 11:26:05 評論於
Does the paper with references have to be less than 5000 words?
(0) 讚! | 八极望亭

作者: 如曼小郎君


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-09 21:54:23 評論於
Which magazine did you subscribe to next?
(0) 讚! | 如曼小郎君

作者: Selena Susanna


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-26 19:57:39 評論於
May I ask which option did you finally choose to vote for? Thank you
(0) 讚! | Selena Susanna

作者: Selena Susanna


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-26 11:58:07 評論於
May I ask which one you finally voted for? Thank you
(0) 讚! | Selena Susanna

作者: Selena Susanna


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-26 09:05:52 評論於
May I ask which stock your last investment was in Pure Growth Fund?
(0) 讚! | Selena Susanna

作者: Selena Susanna


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-25 19:48:16 評論於
May I ask which fund you have invested in? I am also a pure believer
(0) 讚! | Selena Susanna

作者: Selena Susanna


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-25 08:52:36 評論於
Research focus: immunology. Question: Does this journal still accept submissions of raw sequencing data? Thank you
(0) 讚! | Selena Susanna

作者: 四象天欣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 08:04:25 評論於
Can you please tell me how to resolve this issue?
(0) 讚! | 四象天欣

作者: Virgil Vincent


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-10 23:02:58 評論於
Same question, I also want to know if they still accept Pure Life messages
(0) 讚! | Virgil Vincent

作者: Oscar Ferdinand


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-04 11:56:09 評論於
Can you please translate the following paragraph into English and Japanese, with titles ":" and ":"?
(0) 讚! | Oscar Ferdinand

作者: Virgil Vincent


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-02 15:21:26 評論於
May I ask if you accept payments?
(0) 讚! | Virgil Vincent

作者: 雨巷少年怿悦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-15 08:05:08 評論於
How are things going now? I am in the same situation
(0) 讚! | 雨巷少年怿悦

作者: 怀双可爱吗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-17 14:33:16 評論於
I can't submit it either, have you figured it out?
(0) 讚! | 怀双可爱吗

作者: 雨巷少年如筠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-14 09:25:37 評論於
Does this magazine Bioinformatics + Experiments pay for submissions?
(0) 讚! | 雨巷少年如筠

作者: 五毒倩利


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-10 20:23:55 評論於
Do you have any recommendations for publication? I have been looking for journals as well
(0) 讚! | 五毒倩利

作者: 是含文吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-06 12:36:41 評論於
Does the reference count as well?
(0) 讚! | 是含文吖

作者: 星熊廷谦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-22 21:59:03 評論於
Please delete down to 5000 words
(0) 讚! | 星熊廷谦

作者: 魂魄梦寒


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-20 19:03:21 評論於
References are not included
(0) 讚! | 魂魄梦寒

作者: 销魂慧颖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-05 20:28:38 評論於
Why can't the last step of the submission interface for the manuscript be saved, which has been causing a delay in the submission!!!
(0) 讚! | 销魂慧颖

作者: 一只天柔呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-24 19:18:12 評論於
How did you set the 5000-character limit on your system?
(0) 讚! | 一只天柔呀

作者: 一只天柔呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-24 15:28:01 評論於
How do you suggest solving this?
(0) 讚! | 一只天柔呀

作者: 一只天柔呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-24 15:12:00 評論於
Are you following the 5000-word limit? It's difficult to include references within this limit
(0) 讚! | 一只天柔呀

作者: 一只天柔呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-24 08:27:32 評論於
How did you solve it, including references in the word count?
(0) 讚! | 一只天柔呀

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)

開始撰寫 [OncoImmunology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*